Molecular mechanisms of MHC class I-antigen processing: Redox considerations

Antioxidants and Redox Signaling

Volumn 11, Issue 4, 2009, Pages 907-936

  Kim, Youngkyun ^a   Kang, Kwonyoon ^a   Kim, Ilkwon ^a   Lee, Yoon Jeong ^a   Oh, Changhoon ^a   Ryoo, Jeongmin ^a   Jeong, Eunae ^a   Ahn, Kwangseog ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OXIDOREDUCTASE; PROTEIN DISULFIDE ISOMERASE; PROTEIN P57; HLA ANTIGEN CLASS 1; PEPTIDE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BINDING AFFINITY; CATALYSIS; COMPLEX FORMATION; CRYSTAL STRUCTURE; DISULFIDE BOND; ENDOPLASMIC RETICULUM; ENZYME REGULATION; IMMUNOPATHOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN TRANSPORT; QUALITY CONTROL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BINDING SITE; HUMAN; METABOLISM;

ANIMALS; BINDING SITES; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; OXIDATION-REDUCTION; PEPTIDES; PROTEIN FOLDING;

EID: 60749106402     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2316     Document Type: Review

References (322)

1. Abele R and Tampe R. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology (Bethesda) 19: 216-224, 2004.
2. Abrami L, Kunz B, Iacovache I, and van der Goot FG. Palmitoylation and ubiquitination regulate exit of the Wnt signaling protein LRP6 from the endoplasmic reticulum. Proc Natl Acad Sci U S A 105: 5384-5389, 2008.
3. Ackerman AL and Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol 5: 678-684, 2004.
4. Ackerman AL, Kyritsis C, Tampe R, and Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci U S A 100: 12889-12894, 2003.
5. Ahmed R and Gray D. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60, 1996.
6. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, and Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A 93: 10990-10995, 1996.
7. Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, Ploegh HL, Peterson PA, Yang Y, and Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613-621, 1997.
8. Ajitkumar P, Geier SS, Kesari KV, Borriello F, Nakagawa M, Bluestone JA, Saper MA, Wiley DC, and Nathenson SG. Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell 54: 47-56, 1988.
9. 2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 85: 739-745, 1990.
10. Alanen HI, Williamson RA, Howard MJ, Hatahet FS, Salo KE, Kauppila A, Kellokumpu S, and Ruddock LW. ERp27, a new non-catalytic endoplasmic reticulum-located human protein disulfide isomerase family member, interacts with ERp57. J Biol Chem 281: 33727-33738, 2006.
11. Alford CA, Stagno S, Pass RF, and Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 12(suppl 7): S745-S753, 1990.
12. Allen RL, O'Callaghan CA, McMichael AJ, and Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol 162: 5045-5048, 1999.
13. Alom-Ruiz SP, Anilkumar N, and Shah AM. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 10: 1089-1100, 2008.
14. Alvarez I, Marti M, Vazquez J, Camafeita E, Ogueta S, and Lopez de Castro JA. The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation. J Biol Chem 276: 48740-48747, 2001.
15. Anelli T, Alessio M, Bachi A, Bergamelli L, Bertoli G, Camerini S, Mezghrani A, Ruffato E, Simmen T, and Sitia R. Thiol-mediated protein retention in the endoplasmic reticulum: the role of ERp44. EMBO J 22: 5015-5022, 2003.
16. Antoniou AN, Ford S, Alphey M, Osborne A, Elliott T, and Powis SJ. The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules. EMBO J 21: 2655-2663, 2002.
17. Antoniou AN, Ford S, Taurog JD, Butcher GW, and Powis SJ. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J Biol Chem 279: 8895-8902, 2004.
18. Antoniou AN, Powis SJ, and Elliott T. Assembly and export of MHC class I peptide ligands. Curr Opin Immunol 15: 75-81, 2003.
19. Arunachalam B, Phan UT, Geuze HJ, and Cresswell P. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A 97: 745-750, 2000.
20. Baeuerle PA and Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 53: 211-217, 1988.
21. Barbaro G, Di Lorenzo G, Asti A, Ribersani M, Belloni G, Grisorio B, Filice G, and Barbarini G. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol 94: 2198-2205, 1999.
22. Barbirz S, Jakob U, and Glocker MO. Mass spectrometry unravels disulfide bond formation as the mechanism that activates a molecular chaperone. J Biol Chem 275: 18759-18766, 2000.
23. Baumeister W, Walz J, Zuhl F, and Seemuller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92: 367-380, 1998.
24. Beninga J, Rock KL, and Goldberg AL. Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J Biol Chem 273: 18734-18742, 1998.
25. Bernabeu C, van de Rijn M, Lerch PG, and Terhorst CP. Beta 2-microglobulin from serum associates with MHC class I antigens on the surface of cultured cells. Nature 308: 642-645, 1984.
26. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263, 2004.
27. Beutler B. Not "molecular patterns" but molecules. Immunity 19: 155-156, 2003.
28. Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, and Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 33: 748-759, 2003.
29. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, and Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512-518, 1987.
30. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, and Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512, 1987.
31. Braakman I, Helenius J, and Helenius A. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO J 11: 1717-1722, 1992.
32. Brodsky JL and McCracken AA. ER protein quality control and proteasome-mediated protein degradation. Semin Cell Dev Biol 10: 507-513, 1999.
33. Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, Davis MM, Shaw AS, Allen PM, and Dustin ML. The immunological synapse. Annu Rev Immunol 19: 375-396, 2001.
34. Bryant P and Ploegh H. Class II MHC peptide loading by the professionals. Curr Opin Immunol 16: 96-102, 2004.
35. Bukau B and Horwich AL. The Hsp70 and Hsp60 chaperone machines. Cell 92: 351-366, 1998.
36. Buus S, Sette A, and Grey HM. The interaction between protein-derived immunogenic peptides and Ia. Immunol Rev 98: 115-141, 1987.
37. Cabibbo A, Pagani M, Fabbri M, Rocchi M, Farmery MR, Bulleid NJ, and Sitia R. ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum. J Biol Chem 275: 4827-4833, 2000.
38. Cadwell K and Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309: 127-130, 2005.
39. Carey TE, Takahashi T, Resnick LA, Oettgen HF, and Old LJ. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A 73: 3278-3282, 1976.
40. Chambers JE, Jessop CE, and Bulleid NJ. Formation of a major histocompatibility complex class I tapasin disulfide indicates a change in spatial organization of the peptide-loading complex during assembly. J Biol Chem 283: 1862-1869, 2008.
41. Chang SC, Momburg F, Bhutani N, and Goldberg AL. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proc Natl Acad Sci U S A 102: 17107-17112, 2005.
42. Chen W, Helenius J, Braakman I, and Helenius A. Cotranslational folding and calnexin binding during glycoprotein synthesis. Proc Natl Acad Sci U S A 92: 6229-6233, 1995.
43. Chen W, Khilko S, Fecondo J, Margulies DH, and McCluskey J. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med 180: 1471-1483, 1994.
44. Cheung PY and Churchich JE. Recognition of protein substrates by protein-disulfide isomerase: a sequence of the b′ domain responds to substrate binding. J Biol Chem 274: 32757-32761, 1999.
45. Choi J and Ou JH. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290: G847-G851, 2006.
46. Clark R and Kupper T. Old meets new: the interaction between innate and adaptive immunity. J Invest Dermatol 125: 629-637, 2005.
47. Conn KJ, Gao W, McKee A, Lan MS, Ullman MD, Eisenhauer PB, Fine RE, and Wells JM. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res 1022: 164-172, 2004.
48. Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, Schneider M, Beck H, Hatzopoulos AK, Just U, Sinowatz F, Schmahi W, Chien KR, Wurst W, Bornkamm GW, and Brielmeier M. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24: 9414-9423, 2004.
49. Cresswell P and Lanzavecchia A. Antigen processing and recognition. Curr Opin Immunol 13: 11-12, 2001.
50. Dangoria NS, DeLay ML, Kingsbury DJ, Mear JP, Uchanska-Ziegler B, Ziegler A, and Colbert RA. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 277: 23459-23468, 2002.
51. Daniels R, Kurowski B, Johnson AE, and Hebert DN. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol Cell 11: 79-90, 2003.
52. Darby NJ, Penka E, and Vincentelli R. The multidomain structure of protein disulfide isomerase is essential for high catalytic efficiency. J Mol Biol 276: 239-247, 1998.
53. Das KC. Thioredoxin system in premature and newborn biology. Antioxid Redox Signal 6: 177-184, 2004.
54. Das KC, Guo XL, and White CW. Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen. Am J Physiol 276: L530-L539, 1999.
55. David V, Hochstenbach F, Rajagopalan S, and Brenner MB. Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin). J Biol Chem 268: 9585-9592, 1993.
56. Degen E and Williams DB. Participation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules. J Cell Biol 112: 1099-1115, 1991.
57. Demotz S, Grey HM, and Sette A. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249: 1028-1030, 1990.
58. Deprez P, Gautschi M, and Helenius A. More than one glycan is needed for ER glucosidase II to allow entry of glycoproteins into the calnexin/calreticulin cycle. Mol Cell 19: 183-195, 2005.
59. Devary Y, Gottlieb RA, Smeal T, and Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71: 1081-1091, 1992.
60. Devary Y, Rosette C, DiDonato JA, and Karin M. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261: 1442-1445, 1993.
61. Dick TP, Bangia N, Peaper DR, and Cresswell P. Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity 16: 87-98, 2002.
62. Diedrich G, Bangia N, Pan M, and Cresswell P. A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum. J Immunol 166: 1703-1709, 2001.
63. Dong M, Bridges JP, Apsley K, Xu Y, and Weaver TE. ERdj4 and ERdj5 are required for endoplasmic reticulum-associated protein degradation of misfolded surfactant protein C. Mol Biol Cell 19: 2620-2630, 2008.
64. Driscoll J, Brown MG, Finley D, and Monaco JJ. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365: 262-264, 1993.
65. Ellgaard L and Helenius A. ER quality control: towards an understanding at the molecular level. Curr Opin Cell Biol 13: 431-437, 2001.
66. Ellgaard L, Molinari M, and Helenius A. Setting the standards: quality control in the secretory pathway. Science 286: 1882-1888, 1999.
67. Ellgaard L and Ruddock LW. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep 6: 28-32, 2005.
68. Elliott T and Williams A. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunol Rev 207: 89-99, 2005.
69. Farmery MR, Allen S, Allen AJ, and Bulleid NJ. The role of ERp57 in disulfide bond formation during the assembly of major histocompatibility complex class I in a synchronized semipermeabilized cell translation system. J Biol Chem 275: 14933-14938, 2000.
70. Farmery MR and Bulleid NJ. Major histocompatibility class I folding, assembly, and degradation: a paradigm for two-stage quality control in the endoplasmic reticulum. Prog Nucleic Acid Res Mol Biol 67: 235-268, 2001.
71. Farrag HM and Cowett RM. Glucose homeostasis in the micropremie. Clin Perinatol 27: 1-22v, 2000.
72. Fassio A and Sitia R. Formation, isomerisation and reduction of disulphide bonds during protein quality control in the endoplasmic reticulum. Histochem Cell Biol 117: 151-157, 2002.
73. Fearon DT and Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 272: 50-53, 1996.
74. Ferrari DM, Nguyen Van P, Kratzin HD, and Soling HD. ERp28, a human endoplasmic-reticulum-luminal protein, is a member of the protein disulfide isomerase family but lacks a CXXC thioredoxin-box motif. Eur J Biochem 255: 570-579, 1998.
75. Ferrari DM and Soling HD. The protein disulphide-isomerase family: unravelling a string of folds. Biochem J 339: 1-10, 1999.
76. Filomeni G and Ciriolo MR. Redox control of apoptosis: an update. Antioxid Redox Signal 8: 2187-2192, 2006.
77. Finkelman FD, Katona IM, Mosmann TR, and Coffman RL. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 140: 1022-1027, 1988.
78. Flutter B and Gao B. MHC class I antigen presentation: recently trimmed and well presented. Cell Mol Immunol 1: 22-30, 2004.
79. Forster ML, Sivick K, Park YN, Arvan P, Lencer WI, and Tsai B. Protein disulfide isomerase-like proteins play opposing roles during retrotranslocation. J Cell Biol 173: 853-859, 2006.
80. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, and Noelle RJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14: 591-617, 1996.
81. Frand AR and Kaiser CA. Ero1p oxidizes protein disulfide isomerase in a pathway for disulfide bond formation in the endoplasmic reticulum. Mol Cell 4: 469-477, 1999.
82. Frickel EM, Riek R, Jelesarov I, Helenius A, Wuthrich K, and Ellgaard L. TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc Natl Acad Sci U S A 99: 1954-1959, 2002.
83. Friedl P and Storim J. Diversity in immune-cell interactions: states and functions of the immunological synapse. Trends Cell Biol 14: 557-567, 2004.
84. Fuchs J, Ochsendorf F, Schofer H, Milbradt R, and Rubsamen-Waigmann H. Oxidative imbalance in HIV infected patients. Med Hypotheses 36: 60-64, 1991.
85. Gaczynska M, Rock KL, and Goldberg AL. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365: 264-267, 1993.
86. Gaczynska M, Rock KL, Spies T, and Goldberg AL. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci U S A 91: 9213-9217, 1994.
87. Ganz T. Epithelia: not just physical barriers. Proc Natl Acad Sci U S A 99: 3357-3358, 2002.
88. Gao B, Adhikari R, Howarth M, Nakamura K, Gold MC, Hill AB, Knee R, Michalak M, and Elliott T. Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity 16: 99-109, 2002.
89. Garbi N, Tanaka S, Momburg F, and Hammerling GJ. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat Immunol 7: 93-102, 2006.
90. Gess B, Hofbauer KH, Wenger RH, Lohaus C, Meyer HE, and Kurtz A. The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. Eur J Biochem 270: 2228-2235, 2003.
91. Gething MJ. Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol 10: 465-472, 1999.
92. Goldberger RF, Epstein CJ, and Anfinsen CB. Purification and properties of a microsomal enzyme system catalyzing the reactivation of reduced ribonuclease and lysozyme. J Biol Chem 239: 1406-1410, 1964.
93. Grandea AG 3rd, Golovina TN, Hamilton SE, Sriram V, Spies T, Brutkiewicz RR, Harty JT, Eisenlohr LC, and Van Kaer L. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 13: 213-222, 2000.
94. Graumann J, Lilie H, Tang X, Tucker KA, Hoffmann JH, Vijayalakshmi J, Saper M, Bardwell JC, and Jakob U. Activation of the redox-regulated molecular chaperone Hsp33: a two-step mechanism. Structure 9: 377-387, 2001.
95. Groll M, Bajorek M, Kohler A, Moroder L, Rubin DM, Huber R, Glickman MH, and Finley D. A gated channel into the proteasome core particle. Nat Struct Biol 7: 1062-1067, 2000.
96. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, and Huber R. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386: 463-471, 1997.
97. Gromme M and Neefjes J. Antigen degradation or presentation by MHC class I molecules via classical and nonclassical pathways. Mol Immunol 39: 181-202, 2002.
98. Gross E, Sevier CS, Heldman N, Vitu E, Bentzur M, Kaiser CA, Thorpe C, and Fass D. Generating disulfides enzymatically: reaction products and electron acceptors of the endoplasmic reticulum thiol oxidase Ero1p. Proc Natl Acad Sci U S A 103: 299-304, 2006.
99. Gruda R, Achdout H, Stern-Ginossar N, Gazit R, Betser-Cohen G, Manaster I, Katz G, Gonen-Gross T, Tirosh B, and Mandelboim O. Intracellular cysteine residues in the tail of MHC class I proteins are crucial for extracellular recognition by leukocyte Ig-like receptor 1. J Immunol 179: 3655-3661, 2007.
100. Gunther E and Walter L. Comparative genomic aspects of rat, mouse and human MHC class I gene regions. Cytogenet Cell Genet 91: 107-112, 2000.
101. Gurkan C, Stagg SM, Lapointe P, and Balch WE. The COPII cage: unifying principles of vesicle coat assembly. Nat Rev Mol Cell Biol 7: 727-738, 2006.
102. Haas AL and Siepmann TJ. Pathways of ubiquitin conjugation. FASEB J 11: 1257-1268, 1997.
103. Haas AL, Warms JV, Hershko A, and Rose IA. Ubiquitin-activating enzyme: mechanism and role in protein-ubiquitin conjugation. J Biol Chem 257: 2543-2548, 1982.
104. Halaby DM, Poupon A, and Mornon J. The immunoglobulin fold family: sequence analysis and 3D structure comparisons. Protein Eng 12: 563-571, 1999.
105. Hamman BD, Hendershot LM, and Johnson AE. BiP maintains the permeability barrier of the ER membrane by sealing the luminal end of the translocon pore before and early in translocation. Cell 92: 747-758, 1998.
106. Hammerling GJ, Manoury B, Watts C, Adorini L, and Lanzavecchia A. Peptide binding and editing: generation of TCR ligands. Res Immunol 149: 863-865, 1998.
107. Hammond C, Braakman I, and Helenius A. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci U S A 91: 913-917, 1994.
108. Hammond C and Helenius A. Quality control in the secretory pathway. Curr Opin Cell Biol 7: 523-529, 1995.
109. Harding CV and Unanue ER. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346: 574-576, 1990.
110. Harty JT and Badovinac VP. Shaping and reshaping CD8+T-cell memory. Nat Rev Immunol 8: 107-119, 2008.
111. Haugstetter J, Blicher T, and Ellgaard L. Identification and characterization of a novel thioredoxin-related transmembrane protein of the endoplasmic reticulum. J Biol Chem 280: 8371-8380, 2005.
112. Hayano T and Kikuchi M. Molecular cloning of the cDNA encoding a novel protein disulfide isomerase-related protein (PDIR). FEBS Lett 372: 210-214, 1995.
113. Hengel H, Koopmann JO, Flohr T, Muranyi W, Goulmy E, Hammerling GJ, Koszinowski UH, and Momburg F. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6: 623-632, 1997.
114. Hershko A and Ciechanover A. The ubiquitin system. Annu Rev Biochem 67: 425-479, 1998.
115. Hershko A and Ciechanover A. The ubiquitin system for protein degradation. Annu Rev Biochem 61: 761-807, 1992.
116. Hershko A, Eytan E, Ciechanover A, and Haas AL. Immunochemical analysis of the turnover of ubiquitin-protein conjugates in intact cells: relationship to the breakdown of abnormal proteins. J Biol Chem 257: 13964-13970, 1982.
117. Higo T, Hattori M, Nakamura T, Natsume T, Michikawa T, and Mikoshiba K. Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44. Cell 120: 85-98, 2005.
118. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 12(suppl 7): S701-S710, 1990.
119. Hoffmann JH, Linke K, Graf PC, Lilie H, and Jakob U. Identification of a redox-regulated chaperone network. EMBO J 23: 160-168, 2004.
120. Hughes EA and Cresswell P. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr Biol 8: 709-712, 1998.
121. Humphries KM, Szweda PA, and Szweda LI. Aging: a shift from redox regulation to oxidative damage. Free Radic Res 40: 1239-1243, 2006.
122. Hwang C, Sinskey AJ, and Lodish HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257: 1496-1502, 1992.
123. Ioerger TR, Du C, and Linthicum DS. Conservation of cyscys trp structural triads and their geometry in the protein domains of immunoglobulin superfamily members. Mol Immunol 36: 373-386, 1999.
124. Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, and Warnes TW. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 36: 805-811, 2002.
125. Jakob U, Muse W, Eser M, and Bardwell JC. Chaperone activity with a redox switch. Cell 96: 341-352, 1999.
126. Janeway CA Jr. Approaching the asymptote: evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54: 1-13, 1989.
127. Janeway CA Jr and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20: 197-216, 2002.
128. Jensen PE. Recent advances in antigen processing and presentation. Nat Immunol 8: 1041-1048, 2007.
129. Jeong W, Lee DY, Park S, and Rhee SG. ERp16, an endoplasmic reticulum-resident thiol-disulfide oxidoreductase: biochemical properties and role in apoptosis induced by endoplasmic reticulum stress. J Biol Chem 283: 25557-25566, 2008.
130. Jessop CE, Chakravarthi S, Garbi N, Hammerling GJ, Lovell S, and Bulleid NJ. ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. EMBO J 26: 28-40, 2007.
131. Jones TR and Sun L. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J Virol 71: 2970-2979, 1997.
132. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, and Ploegh HL. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A 93: 11327-11333, 1996.
133. Kaiser BK, Yim D, Chow IT, Gonzalez S, Dai Z, Mann HH, Strong RK, Groh V, and Spies T. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447: 482-486, 2007.
134. Kang JG, Hahn MY, Ishihama A, and Roe JH. Identification of sigma factors for growth phase-related promoter selectivity of RNA polymerases from Streptomyces coelicolor A3(2). Nucleic Acids Res 25: 2566-2573, 1997.
135. Kang JG, Paget MS, Seok YJ, Hahn MY, Bae JB, Hahn JS, Kleanthous C, Buttner MJ, and Roe JH. RsrA, an anti-sigma factor regulated by redox change. EMBO J 18: 4292-4298, 1999.
136. Kang SJ and Cresswell P. Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J Biol Chem 277: 44838-44844, 2002.
137. Kappes D and Strominger JL. Human class II major histocompatibility complex genes and proteins. Annu Rev Biochem 57: 991-1028, 1988.
138. Kienast A, Preuss M, Winkler M, and Dick TP. Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin. Nat Immunol 8: 864-872, 2007.
139. Klappa P, Freedman RB, Langenbuch M, Lan MS, Robinson GK, and Ruddock LW. The pancreas-specific protein disulphide-isomerase PDIp interacts with a hydroxyaryl group in ligands. Biochem J 354: 553-559, 2001.
140. Klappa P, Ruddock LW, Darby NJ, and Freedman RB. The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins. EMBO J 17: 927-935, 1998.
141. Kloetzel PM. Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2: 179-187, 2001.
142. Knittler MR, Alberts P, Deverson EV, and Howard JC. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules. Curr Biol 9: 999-1008, 1999.
143. Knoblach B, Keller BO, Groenendyk J, Aldred S, Zheng J, Lemire BD, Li L, and Michalak M. ERp19 and ERp46, new members of the thioredoxin family of endoplasmic reticulum proteins. Mol Cell Proteomics 2: 1104-1119, 2003.
144. Knuth A, Danowski B, Oettgen HF, and Old LJ. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. Proc Natl Acad Sci U S A 81: 3511-3515, 1984.
145. Koch J, Guntrum R, Heintke S, Kyritsis C, and Tampe R. Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP). J Biol Chem 279: 10142-10147, 2004.
146. Koch J, Guntrum R, and Tampe R. Exploring the minimal functional unit of the transporter associated with antigen processing. FEBS Lett 579: 4413-4416, 2005.
147. Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, Breban M, McMichael AJ, and Bowness P. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 173: 1699-1710, 2004.
148. Krawczyk CM, Shen H, and Pearce EJ. Memory CD4 T cells enhance primary CD8 T-cell responses. Infect Immun 75: 3556-3560, 2007.
149. Kulp MS, Frickel EM, Ellgaard L, and Weissman JS. Domain architecture of protein-disulfide isomerase facilitates its dual role as an oxidase and an isomerase in Ero1p-mediated disulfide formation. J Biol Chem 281: 876-884, 2006.
150. Ladasky JJ, Boyle S, Seth M, Li H, Pentcheva T, Abe F, Steinberg SJ, and Edidin M. Bap31 enhances the endoplasmic reticulum export and quality control of human class I MHC molecules. J Immunol 177: 6172-6181, 2006.
151. Lammert E, Stevanovic S, Brunner J, Rammensee HG, and Schild H. Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum. Eur J Immunol 27: 1685-1690, 1997.
152. Lander HM, Sehajpal P, Levine DM, and Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 150: 1509-1516, 1993.
153. Lappi AK, Lensink MF, Alanen HI, Salo KE, Lobell M, Juffer AH, and Ruddock LW. A conserved arginine plays a role in the catalytic cycle of the protein disulphide isomerases. J Mol Biol 335: 283-295, 2004.
154. Laupeze B, Fardel O, Onno M, Bertho N, Drenou B, Fauchet R, and Amiot L. Differential expression of major histocompatibility complex class Ia, Ib, and II molecules on monocytes-derived dendritic and macrophagic cells. Hum Immunol 60: 591-597, 1999.
155. Lauvau G, Vijh S, Kong P, Horng T, Kerksiek K, Serbina N, Tuma RA, and Pamer EG. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294: 1735-1739, 2001.
156. Leach MR, Cohen-Doyle MF, Thomas DY, and Williams DB. Localization of the lectin, ERp57 binding, and polypeptide binding sites of calnexin and calreticulin. J Biol Chem 277: 29686-29697, 2002.
157. Lee MC, Miller EA, Goldberg J, Orci L, and Schekman R. Bi-directional protein transport between the ER and Golgi. Annu Rev Cell Dev Biol 20: 87-123, 2004.
158. Lehner PJ, Surman MJ, and Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity 8: 221-231, 1998.
159. Lenardo MJ and Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229, 1989.
160. Lewis JW and Elliott T. Evidence for successive peptide binding and quality control stages during MHC class I assembly. Curr Biol 8: 717-720, 1998.
161. Lilley BN and Ploegh HL. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev 207: 126-144, 2005.
162. Lindquist JA, Hammerling GJ, and Trowsdale J. ER60/ERp57 forms disulfide-bonded intermediates with MHC class I heavy chain. FASEB J 15: 1448-1450, 2001.
163. Lopez-Mirabal HR and Winther JR. Redox characteristics of the eukaryotic cytosol. Biochim Biophys Acta 1783: 629-640, 2008.
164. Loureiro J and Ploegh HL. Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv Immunol 92: 225-305, 2006.
165. Lumb RA and Bulleid NJ. Is protein disulfide isomerase a redox-dependent molecular chaperone? EMBO J 21: 6763-6770, 2002.
166. Macer DR and Koch GL. Identification of a set of calcium-binding proteins in reticuloplasm, the luminal content of the endoplasmic reticulum. J Cell Sci 91: 61-70, 1988.
167. Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G, Ikeda H, Hanano S, Suehiro M, Togawa K, and Yamada G. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal 6: 19-24, 2004.
168. Malik P, Klimovitsky P, Deng LW, Boyson JE, and Strominger JL. Uniquely conformed peptide-containing beta 2-microglobulin-free heavy chains of HLA-B2705 on the cell surface. J Immunol 169: 4379-4387, 2002.
169. Mann DW, McLaughlin-Taylor E, Wallace RB, and Forman J. An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes. J Exp Med 168: 307-324, 1988.
170. Marguet D, Spiliotis ET, Pentcheva T, Lebowitz M, Schneck J, and Edidin M. Lateral diffusion of GFP-tagged H2Ld molecules and of GFP-TAP1 reports on the assembly and retention of these molecules in the endoplasmic reticulum. Immunity 11: 231-240, 1999.
171. Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, Cannon KS, Alfonso C, Karlsson L, Flavell RA, and Cresswell P. Defective antigen processing in GILT-free mice. Science 294: 1361-1365, 2001.
172. Marquardt T, Hebert DN, and Helenius A. Post-translational folding of influenza hemagglutinin in isolated endoplasmic reticulum-derived microsomes. J Biol Chem 268: 19618-19625, 1993.
173. Masutani H, Ueda S, and Yodoi J. The thioredoxin system in retroviral infection and apoptosis. Cell Death Differ 12(suppl 1): 991-998, 2005.
174. Mates JM, Segura JA, Alonso FJ, and Marquez J. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 82: 273-299, 2008.
175. Matsuo Y, Akiyama N, Nakamura H, Yodoi J, Noda M, and Kizaka-Kondoh S. Identification of a novel thioredoxin-related transmembrane protein. J Biol Chem 276: 10032-10038, 2001.
176. Matsuoka K, Orci L, Amherdt M, Bednarek SY, Hamamoto S, Schekman R, and Yeung T. COPII-coated vesicle formation reconstituted with purified coat proteins and chemically defined liposomes. Cell 93: 263-275, 1998.
177. Medzhitov R, Preston-Hurlburt P, and Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397, 1997.
178. Melnick J, Dul JL, and Argon Y. Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum. Nature 370: 373-375, 1994.
179. Meng X, Zhang C, Chen J, Peng S, Cao Y, Ying K, Xie Y, and Mao Y. Cloning and identification of a novel cDNA coding thioredoxin-related transmembrane protein 2. Biochem Genet 41: 99-106, 2003.
180. Mesaeli N, Nakamura K, Zvaritch E, Dickie P, Dziak E, Krause KH, Opas M, MacLennan DH, and Michalak M. Calreticulin is essential for cardiac development. J Cell Biol 144: 857-868, 1999.
181. Meusser B, Hirsch C, Jarosch E, and Sommer T. ERAD: the long road to destruction. Nat Cell Biol 7: 766-772, 2005.
182. Meyer T, Stockfleth E, and Christophers E. Immune response profiles in human skin. Br J Dermatol 157(suppl 2): 1-7, 2007.
183. Meyer TH, van Endert PM, Uebel S, Ehring B, and Tampe R. Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett 351: 443-447, 1994.
184. Mezzacasa A and Helenius A. The transitional ER defines a boundary for quality control in the secretion of tsO45 VSV glycoprotein. Traffic 3: 833-849, 2002.
185. Molinari M. N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol 3: 313-320, 2007.
186. Molinari M, Galli C, Vanoni O, Arnold SM, and Kaufman RJ. Persistent glycoprotein misfolding activates the glucosidase II/UGT1-driven calnexin cycle to delay aggregation and loss of folding competence. Mol Cell 20: 503-512, 2005.
187. Molinari M and Helenius A. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288: 331-333, 2000.
188. Molinari M and Helenius A. Glycoproteins form mixed disulphides with oxidoreductases during folding in living cells. Nature 402: 90-93, 1999.
189. Momburg F, Roelse J, Howard JC, Butcher GW, Hammerling GJ, and Neefjes JJ. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367: 648-651, 1994.
190. Munro S and Pelham HR. An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 46: 291-300, 1986.
191. Murata S, Sasaki K, Kishimoto T, Niwa S, Hayashi H, Takahama Y, and Tanaka K. Regulation of CD8+T cell development by thymus-specific proteasomes. Science 316: 1349-1353, 2007.
192. Murata S, Takahama Y, and Tanaka K. Thymoproteasome: probable role in generating positively selecting peptides. Curr Opin Immunol 20: 192-196, 2008.
193. Murata S, Udono H, Tanahashi N, Hamada N, Watanabe K, Adachi K, Yamano T, Yui K, Kobayashi N, Kasahara M, Tanaka K, and Chiba T. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. EMBO J 20: 5898-5907, 2001.
194. Nabel G and Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713, 1987.
195. Nakashima I, Pu MY, Nishizaki A, Rosila I, Ma L, Katano Y, Ohkusu K, Rahman SM, Isobe K, Hamaguchi M, and Saga KK. Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals. J Immunol 152: 1064-1071, 1994.
196. Neefjes JJ and Ploegh HL. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol 18: 801-810, 1988.
197. Neisig A, Wubbolts R, Zang X, Melief C, and Neefjes J. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J Immunol 156: 3196-3206, 1996.
198. Neumann L and Tampe R. Kinetic analysis of peptide binding to the TAP transport complex: evidence for structural rearrangements induced by substrate binding. J Mol Biol 294: 1203-1213, 1999.
199. Nikolic-Zugic J and Carbone FR. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant. Eur J Immunol 20: 2431-2437, 1990.
200. Noiva R. Protein disulfide isomerase: the multifunctional redox chaperone of the endoplasmic reticulum. Semin Cell Dev Biol 10: 481-493, 1999.
201. Norgaard P and Winther JR. Mutation of yeast Eug1p CXXS active sites to CXXC results in a dramatic increase in protein disulphide isomerase activity. Biochem J 358: 269-274, 2001.
202. Nossner E and Parham P. Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J Exp Med 181: 327-337, 1995.
203. Obeid M. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin. J Immunol 181: 2533-2543, 2008.
204. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, and Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244: 974-976, 1989.
205. Oliver JD, Roderick HL, Llewellyn DH, and High S. ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin. Mol Biol Cell 10: 2573-2582, 1999.
206. Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, Grandea AG, Riddell SR, Tampe R, Spies T, Trowsdale J, and Cresswell P. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277: 1306-1309, 1997.
207. Ostergaard Pedersen L, Nissen MH, Hansen NJ, Nielsen LL, Lauenmoller SL, Blicher T, Nansen A, Sylvester-Hvid C, Thromsen AR, and Buus S. Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds. Eur J Immunol 31: 2986-2996, 2001.
208. Otsu M, Bertoli G, Fagioli C, Guerini-Rocco E, Nerini-Molteni S, Ruffato E, and Sitia R. Dynamic retention of Ero1alpha and Ero1beta in the endoplasmic reticulum by interactions with PDI and ERp44. Antioxid Redox Signal 8: 274-282, 2006.
209. Ozaki M, Deshpande S, Angkeow P, Bellan J, Lowenstein CJ, Dinauer MC, Goldschmidt-Clermont P, Suzuki S, and Irani K. Targeted inhibition of the small GTPase protects against ischemia/reperfusion liver injury in mice. Transplant Proc 33: 863-864, 2001.
210. Pagani M, Fabbri M, Benedetti C, Fassio A, Pilati S, Bulleid NJ, Cabibbo A, and Sitia R. Endoplasmic reticulum oxidoreductin 1-lbeta (ERO1-Lbeta), a human gene induced in the course of the unfolded protein response. J Biol Chem 275: 23685-23692, 2000.
211. Paget MS and Buttner MJ. Thiol-based regulatory switches. Annu Rev Genet 37: 91-121, 2003.
212. Paget MS, Kang JG, Roe JH, and Buttner MJ. Sigmar, an RNA polymerase sigma factor that modulates expression of the thioredoxin system in response to oxidative stress in Streptomyces coelicolor A3(2). EMBO J 17: 5776-5782, 1998.
213. Pamer E and Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 16: 323-358, 1998.
214. Paquet ME, Cohen-Doyle M, Shore GC, and Williams DB. Bap29/31 influences the intracellular traffic of MHC class I molecules. J Immunol 172: 7548-7555, 2004.
215. Parham P. Antigen presentation by class I major histocompatibility complex molecules: a context for thinking about HLA-G. Am J Reprod Immunol 34: 10-19, 1995.
216. Parish CR and O'Neill ER. Dependence of the adaptive immune response on innate immunity: some questions answered but new paradoxes emerge. Immunol Cell Biol 75: 523-527, 1997.
217. Park B, Lee S, Kim E, and Ahn K. A single polymorphic residue within the peptide-binding cleft of MHC class I molecules determines spectrum of tapasin dependence. J Immunol 170: 961-968, 2003.
218. Park B, Lee S, Kim E, Cho K, Riddell SR, Cho S, and Ahn K. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127: 369-382, 2006.
219. Parodi AJ. Protein glucosylation and its role in protein folding. Annu Rev Biochem 69: 69-93, 2000.
220. Paulsson KM. Evolutionary and functional perspectives of the major histocompatibility complex class I antigen-processing machinery. Cell Mol Life Sci 61: 2446-2460, 2004.
221. Peaper DR and Cresswell P. The redox activity of ERp57 is not essential for its functions in MHC class I peptide loading. Proc Natl Acad Sci U S A 105: 10477-10482, 2008.
222. Peaper DR, Wearsch PA, and Cresswell P. Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J 24: 3613, 2005.
223. Peh CA, Burrows SR, Barnden M, Khanna R, Cresswell P, Moss DJ, and McCluskey J. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8: 531-542, 1998.
224. Pentcheva T and Edidin M. Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer. J Immunol 166: 6625-6632, 2001.
225. Pfaff E, Mussgay M, Bohm HO, Schulz GE, and Schaller H. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J 1: 869-874, 1982.
226. Pirneskoski A, Klappa P, Lobell M, Williamson RA, Byrne L, Alanen HI, Salo KE, Kivirikko KI, Freedman RB, and Ruddock LW. Molecular characterization of the principal substrate binding site of the ubiquitous folding catalyst protein disulfide isomerase. J Biol Chem 279: 10374-10381, 2004.
227. Pollard MG, Travers KJ, and Weissman JS. Ero1p: a novel and ubiquitous protein with an essential role in oxidative protein folding in the endoplasmic reticulum. Mol Cell 1: 171-182, 1998.
228. Powis G and Kirkpatrick DL. Thioredoxin signaling as a target for cancer therapy. Curr Opin Pharmacol 7: 392-397, 2007.
229. Radosavljevic M, Cuillerier B, Wilson MJ, Clement O, Wicker S, Gilfillan S, Beck S, Trowsdale J, and Bahram S. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 79: 114-123, 2002.
230. Raman B, Siva Kumar LV, Ramakrishna T, and Mohan Rao C. Redox-regulated chaperone function and conformational changes of Escherichia coli Hsp33. FEBS Lett 489: 19-24, 2001.
231. Ramos M and Lopez de Castro JA. HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens 60: 191-205, 2002.
232. Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5: 996-1002, 2004.
233. Reimann J and Kaufmann SH. Alternative antigen processing pathways in anti-infective immunity. Curr Opin Immunol 9: 462-469, 1997.
234. Reiser JB, Darnault C, Guimezanes A, Gregoire C, Mosser T, Schmitt-Verhulst AM, Fontecilla-Camps JC, Malissen B, Housset D, and Mazza G. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat Immunol 1: 291-297, 2000.
235. Reits E, Griekspoor A, Neijssen J, Groothuis T, Jalink K, van Veelen P, Janssen H, Calafat J, Drijfhout JW, and Neefjes J. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18: 97-108, 2003.
236. Ribaudo RK and Margulies DH. Independent and synergistic effects of disulfide bond formation, beta 2-microglobulin, and peptides on class I MHC folding and assembly in an in vitro translation system. J Immunol 149: 2935-2944, 1992.
237. Rock KL and Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 17: 739-779, 1999.
238. Ronaldson PT and Bendayan R. HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells. J Neurochem 106: 1298-1313, 2008.
239. Rudd PM, Elliott T, Cresswell P, Wilson IA, and Dwek RA. Glycosylation and the immune system. Science 291: 2370-2376, 2001.
240. Russell SJ, Ruddock LW, Salo KE, Oliver JD, Roebuck QP, Llewellyn DH, Roderick HL, Koivunen P, Myllyharju J, and High S. The primary substrate binding site in the b′ domain of ERp57 is adapted for endoplasmic reticulum lectin association. J Biol Chem 279: 18861-18869, 2004.
241. Ryan KJ, Ray G, and Sherris J. Sherris Medical Microbiology: An Introduction to Infectious Diseases. New York, NY: McGraw-Hill Professional, 2004. pp. 556, 566-559.
242. Sadasivan B, Lehner PJ, Ortmann B, Spies T, and Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5: 103-114, 1996.
243. Santos SG, Campbell EC, Lynch S, Wong V, Antoniou AN, and Powis SJ. Major histocompatibility complex class I-ERp57-tapasin interactions within the peptide-loading complex. J Biol Chem 282: 17587-17593, 2007.
244. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
245. Scheffner M, Nuber U, and Huibregtse JM. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373: 81-83, 1995.
246. Schieven GL, Kirihara JM, Burg DL, Geahlen RL, and Ledbetter JA. p72syk tyrosine kinase is activated by oxidizing conditions that induce lymphocyte tyrosine phosphorylation and Ca2+signals. J Biol Chem 268: 16688-16692, 1993.
247. Schieven GL, Mittler RS, Nadler SG, Kirihara JM, Bolen JB, Kanner SB, and Ledbetter JA. ZAP-70 tyrosine kinase, CD45, and T cell receptor involvement in UV- and H2O2-induced T cell signal transduction. J Biol Chem 269: 20718-20726, 1994.
248. Schmitt L and Tampe R. Structure and mechanism of ABC transporters. Curr Opin Struct Biol 12: 754-760, 2002.
249. Schoenhals GJ, Krishna RM, Grandea AG 3rd, Spies T, Peterson PA, Yang Y, and Fruh K. Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. EMBO J 18: 743-753, 1999.
250. Scholz C and Tampe R. The intracellular antigen transport machinery TAP in adaptive immunity and virus escape mechanisms. J Bioenerg Biomembr 37: 509-515, 2005.
251. Sears CL and Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev 60: 167-215, 1996.
252. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55: 1747-1758, 1998.
253. Seronello S, Sheikh MY, and Choi J. Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic Biol Med 43: 869-882, 2007.
254. Serwold T, Gonzalez F, Kim J, Jacob R, and Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-483, 2002.
255. Sevier CS and Kaiser CA. Formation and transfer of disulphide bonds in living cells. Nat Rev Mol Cell Biol 3: 836-847, 2002.
256. Shamu CE, Story CM, Rapoport TA, and Ploegh HL. The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate. J Cell Biol 147: 45-58, 1999.
257. Sherman LA and Chattopadhyay S. The molecular basis of allorecognition. Annu Rev Immunol 11: 385-402, 1993.
258. Shiroishi T, Evans GA, Appella E, and Ozato K. Role of a disulfide bridge in the immune function of major histocompatibility class I antigen as studied by in vitro mutagenesis. Proc Natl Acad Sci U S A 81: 7544-7548, 1984.
259. Sieker F, Straatsma TP, Springer S, and Zacharias M. Differential tapasin dependence of MHC class I molecules correlates with conformational changes upon peptide dissociation: a molecular dynamics simulation study. Mol Immunol 45: 3714-3722, 2008.
260. Sitia R and Braakman I. Quality control in the endoplasmic reticulum protein factory. Nature 426: 891-894, 2003.
261. Smith JD, Solheim JC, Carreno BM, and Hansen TH. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin. Mol Immunol 32: 531-540, 1995.
262. Solda T, Garbi N, Hammerling GJ, and Molinari M. Consequences of ERp57 deletion on oxidative folding of obligate and facultative clients of the calnexin cycle. J Biol Chem 281: 6219-6226, 2006.
263. Solheim JC, Harris MR, Kindle CS, and Hansen TH. Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J Immunol 158: 2236-2241, 1997.
264. Spee P and Neefjes J. TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin. Eur J Immunol 27: 2441-2449, 1997.
265. Spiliotis ET, Manley H, Osorio M, Zuniga MC, and Edidin M. Selective export of MHC class I molecules from the ER after their dissociation from TAP. Immunity 13: 841-851, 2000.
266. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 20: 395-425, 2002.
267. Staal FJ, Roederer M, Herzenberg LA, and Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 87: 9943-9947, 1990.
268. Stepensky D, Bangia N, and Cresswell P. Aggregate formation by ERp57-deficient MHC class I peptide-loading complexes. Traffic 8: 1530-1542, 2007.
269. Stoltze L, Schirle M, Schwarz G, Schroter C, Thompson MW, Hersh LB, Kalbacher H, Stevanovic S, Rammensee HG, and Schild H. Two new proteases in the MHC class I processing pathway. Nat Immunol 1: 413-418, 2000.
270. Stronge VS, Saito Y, Ihara Y, and Williams DB. Relationship between calnexin and BiP in suppressing aggregation and promoting refolding of protein and glycoprotein substrates. J Biol Chem 276: 39779-39787, 2001.
271. Suh JK, Poulsen LL, Ziegler DM, and Robertus JD. Yeast flavin-containing monooxygenase generates oxidizing equivalents that control protein folding in the endoplasmic reticulum. Proc Natl Acad Sci U S A 96: 2687-2691, 1999.
272. Suh WK, Cohen-Doyle MF, Fruh K, Wang K, Peterson PA, and Williams DB. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264: 1322-1326, 1994.
273. Suh WK, Mitchell EK, Yang Y, Peterson PA, Waneck GL, and Williams DB. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J Exp Med 184: 337-348, 1996.
274. Sun R, Shepherd SE, Geier SS, Thomson CT, Sheil JM, and Nathenson SG. Evidence that the antigen receptors of cytotoxic T lymphocytes interact with a common recognition pattern on the H-2Kb molecule. Immunity 3: 573-582, 1995.
275. Swietek K and Juszczyk J. Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J Viral Hepatol 4: 139-141, 1997.
276. Tanaka K and Kasahara M. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol Rev 163: 161-176, 1998.
277. Tangye SG, Avery DT, Deenick EK, and Hodgkin PD. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J Immunol 170: 686-694, 2003.
278. Tangye SG, Avery DT, and Hodgkin PD. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol 170: 261-269, 2003.
279. Tatu U and Helenius A. Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum. J Cell Biol 136: 555-565, 1997.
280. Tector M, Zhang Q, and Salter RD. [beta]2-Microglobulin and calnexin can independently promote folding and disulfide bond formation in class I histocompatibility proteins. Mol Immunol 34: 401-408, 1997.
281. Tian G, Xiang S, Noiva R, Lennarz WJ, and Schindelin H. The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites. Cell 124: 61-73, 2006.
282. Towne CF, York IA, Neijssen J, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Neefjes JJ, and Rock KL. Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation. J Immunol 175: 6605-6614, 2005.
283. Towne CF, York IA, Neijssen J, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Neefjes JJ, and Rock KL. Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections. J Immunol 180: 1704-1712, 2008.
284. Towne CF, York IA, Watkin LB, Lazo JS, and Rock KL. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses. J Immunol 178: 6923-6930, 2007.
285. Tran TM, Satumtira N, Dorris ML, May E, Wang A, Furuta E, and Taurog JD. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. J Immunol 172: 5110-5119, 2004.
286. Tsai B, Rodighiero C, Lencer WI, and Rapoport TA. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 104: 937-948, 2001.
287. Tsibris JC, Hunt LT, Ballejo G, Barker WC, Toney LJ, and Spellacy WN. Selective inhibition of protein disulfide isomerase by estrogens. J Biol Chem 264: 13967-13970, 1989.
288. Tu BP, Ho-Schleyer SC, Travers KJ, and Weissman JS. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science 290: 1571-1574, 2000.
289. Tu BP and Weissman JS. Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol 164: 341-346, 2004.
290. Turnquist HR, Petersen JL, Vargas SE, McIlhaney MM, Bedows E, Mayer WE, Grandea AG 3rd, Van Kaer L, and Solheim JC. The Ig-like domain of tapasin influences intermolecular interactions. J Immunol 172: 2976-2984, 2004.
291. Uckun FM, Schieven GL, Tuel-Ahlgren LM, Dibirdik I, Myers DE, Ledbetter JA, and Song CW. Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors. Proc Natl Acad Sci U S A 90: 252-256, 1993.
292. Uebel S, Meyer TH, Kraas W, Kienle S, Jung G, Wiesmuller KH, and Tampe R. Requirements for peptide binding to the human transporter associated with antigen processing revealed by peptide scans and complex peptide libraries. J Biol Chem 270: 18512-18516, 1995.
293. Ushioda R, Hoseki J, Araki K, Jansen G, Thomas DY, and Nagata K. ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER. Science 321: 569-572, 2008.
294. van Anken E and Braakman I. Versatility of the endoplasmic reticulum protein folding factory. Crit Rev Biochem Mol Biol 40: 191-228, 2005.
295. Van den Berg B, Clemons WM Jr, Collinson I, Modis Y, Hartmann E, Harrison SC, and Rapoport TA. X-ray structure of a protein-conducting channel. Nature 427: 36-44, 2004.
296. Van Kaer L. Major histocompatibility complex class I-restricted antigen processing and presentation. Tissue Antigens 60: 1-9, 2002.
297. van Lith M, Hartigan N, Hatch J, and Benham AM. PDILT, a divergent testis-specific protein disulfide isomerase with a non-classical SXXC motif that engages in disulfide-dependent interactions in the endoplasmic reticulum. J Biol Chem 280: 1376-1383, 2005.
298. Vassilakos A, Cohen-Doyle MF, Peterson PA, Jackson MR, and Williams DB. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J 15: 1495-1506, 1996.
299. von Andrian UH and Mackay CR. T-cell function and migration: two sides of the same coin. N Engl J Med 343: 1020-1034, 2000.
300. Wang EW, Kessler BM, Borodovsky A, Cravatt BF, Bogyo M, Ploegh HL, and Glas R. Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. Proc Natl Acad Sci U S A 97: 9990-9995, 2000.
301. Wang H, Capps GG, Robinson BE, and Zuniga MC. Ab initio association with beta 2-microglobulin during biosynthesis of the H-2Ld class I major histocompatibility complex heavy chain promotes proper disulfide bond formation and stable peptide binding. J Biol Chem 269: 22276-22281, 1994.
302. Wang N, Daniels R, and Hebert DN. The cotranslational maturation of the type I membrane glycoprotein tyrosinase: the heat shock protein 70 system hands off to the lectin-based chaperone system. Mol Biol Cell 16: 3740-3752, 2005.
303. Warburton RJ, Matsui M, Rowland-Jones SL, Gammon MC, Katzenstein GE, Wei T, Edidin M, Zweerink HJ, McMichael AJ, and Frelinger JA. Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLAA* 0201: effect on maturation and peptide presentation. Hum Immunol 39: 261-271, 1994.
304. Wearsch PA and Cresswell P. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol 8: 873-881, 2007.
305. Wedemayer GJ, Patten PA, Wang LH, Schultz PG, and Stevens RC. Structural insights into the evolution of an antibody combining site. Science 276: 1665-1669, 1997.
306. Westphal V, Darby NJ, and Winther JR. Functional properties of the two redox-active sites in yeast protein disulphide isomerase in vitro and in vivo. J Mol Biol 286: 1229-1239, 1999.
307. Wieland FT, Gleason ML, Serafini TA, and Rothman JE. The rate of bulk flow from the endoplasmic reticulum to the cell surface. Cell 50: 289-300, 1987.
308. Wiertz E, Hill A, Tortorella D, and Ploegh H. Cytomegaloviruses use multiple mechanisms to elude the host immune response. Immunol Lett 57: 213-216, 1997.
309. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, and Ploegh HL. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779, 1996.
310. Wilkinson KD, Urban MK, and Haas AL. Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J Biol Chem 255: 7529-7532, 1980.
311. Williams A, Peh CA, and Elliott T. The cell biology of MHC class I antigen presentation. Tissue Antigens 59: 3-17, 2002.
312. Williams AP, Peh CA, Purcell AW, McCluskey J, and Elliott T. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16: 509-520, 2002.
313. Wilson R, Lees JF, and Bulleid NJ. Protein disulfide isomerase acts as a molecular chaperone during the assembly of procollagen. J Biol Chem 273: 9637-9643, 1998.
314. Yewdell JW, Reits E, and Neefjes J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol 3: 952-961, 2003.
315. York IA, Bhutani N, Zendzian S, Goldberg AL, and Rock KL. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation. J Immunol 177: 1434-1443, 2006.
316. York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, and Rock KL. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 3: 1177-1184, 2002.
317. York IA, Goldberg AL, Mo XY, and Rock KL. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev 172: 49-66, 1999.
318. Yoshino M, Xiao H, Jones EP, Kumanovics A, Amadou C, and Fischer Lindahl K. Genomic evolution of the distal MHC class I region on mouse Chr 17. Hereditas 127: 141-148, 1997.
319. Zhang K and Kaufman RJ. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66: S102-S109, 2006.
320. Zhang Y, Baig E, and Williams DB. Functions of ERp57 in the folding and assembly of major histocompatibility complex class I molecules. J Biol Chem 281: 14622-14631, 2006.
321. Zhang Y and Williams DB. Assembly of MHC class I molecules within the endoplasmic reticulum. Immunol Res 35: 151-162, 2006.
322. Zhou M, Jacob A, Ho N, Miksa M, Wu R, Maitra SR, and Wang P. Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release. Crit Care 12: R100, 2008.